Cogent Biosciences (COGT) Cash flow

719 Followers

Cogent Biosciences Cash Flow

COGT's free cash flow for Q4 2025 was $-79.92M. For the 2025 fiscal year, COGT's free cash flow was decreased by $-57.63M and operating cash flow was $-79.11M. See a summary of the company’s cash flow.

Cash Flow	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Operating Cash Flow	$ -264.44M	$ -207.79M	$ -153.62M	$ -118.64M	$ -58.76M
Investing Cash Flow	$ -399.53M	$ 38.28M	$ -97.82M	$ -124.72M	$ -1.72M
Financing Cash Flow	$ 878.23M	$ 214.45M	$ 163.54M	$ 163.56M	$ 37.98M
End Cash Position	$ 312.43M	$ 98.17M	$ 53.23M	$ 141.14M	$ 220.94M
Free Cash Flow	$ -266.00M	$ -208.36M	$ -156.42M	$ -125.50M	$ -60.48M

Currency in USD